To study the effect of Nalbuphine in prolongation of duration of post-operative analgesia when it is added as an adjuvant to 0.5%Ropivacaine in ultrasound guided supraclavicular brachial plexus blocks
Phase 3
- Conditions
- Health Condition 1: S52- Fracture of forearm
- Registration Number
- CTRI/2022/06/043470
- Lead Sponsor
- Department of Anaesthesia
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.participant of fracture forearm surgeries under USG guided supraclavicular block. 2. ASA physical status class 1and 2 . 3. patients willing to participate.
Exclusion Criteria
1. Patients with a history of allergy or hypersensitivity to either local anaesthetics or opioid group of drugs. 2. Any contra indication to peripheral nerve block. 3.impaired ability to communicate. 4.patients with raised intracranial tension. 5.pregnancy. 6.patient with coagulation disorder. 7.local infection/swelling at the site of injection.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Duration of post-operative analgesia according to NRS scale.(time of first request of rescue analgesia).Timepoint: Every 30 minutes in first hour then every one hourly in next twelve hours.
- Secondary Outcome Measures
Name Time Method Haemodynamic parametersTimepoint: Intraoperative period;Mean duration of analgesiaTimepoint: In post-operative period;Proportion of cases with complicationsTimepoint: Post operative period;Side-effectsTimepoint: If any